With reported 3x speed gains and limited degradation in output quality, the method targets one of the biggest pain points in production AI systems: latency at scale.
Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results